U.S. flag

An official website of the United States government

NM_000257.4(MYH7):c.1357C>T (p.Arg453Cys) AND Hypertrophic cardiomyopathy 1

Germline classification:
Pathogenic/Likely pathogenic (4 submissions)
Last evaluated:
Jun 27, 2023
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000015145.34

Allele description [Variation Report for NM_000257.4(MYH7):c.1357C>T (p.Arg453Cys)]

NM_000257.4(MYH7):c.1357C>T (p.Arg453Cys)

Gene:
MYH7:myosin heavy chain 7 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
14q11.2
Genomic location:
Preferred name:
NM_000257.4(MYH7):c.1357C>T (p.Arg453Cys)
Other names:
p.R453C:CGC>TGC; NM_000257.3(MYH7):c.1357C>T
HGVS:
  • NC_000014.9:g.23429005G>A
  • NG_007884.1:g.11657C>T
  • NM_000257.4:c.1357C>TMANE SELECT
  • NP_000248.2:p.Arg453Cys
  • LRG_384t1:c.1357C>T
  • LRG_384:g.11657C>T
  • NC_000014.8:g.23898214G>A
  • NM_000257.2:c.1357C>T
  • NM_000257.3:c.1357C>T
  • P12883:p.Arg453Cys
  • c.1357C>T
Protein change:
R453C; ARG453CYS
Links:
UniProtKB: P12883#VAR_004576; OMIM: 160760.0003; dbSNP: rs121913625
NCBI 1000 Genomes Browser:
rs121913625
Molecular consequence:
  • NM_000257.4:c.1357C>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
1

Condition(s)

Name:
Hypertrophic cardiomyopathy 1
Synonyms:
Familial hypertrophic cardiomyopathy 1; MYH7-Related Familial Hypertrophic Cardiomyopathy
Identifiers:
MONDO: MONDO:0008647; MedGen: C3495498; OMIM: 192600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000035402OMIM
no assertion criteria provided
Pathogenic
(May 1, 1996)
germlineliterature only

PubMed (2)
[See all records that cite these PMIDs]

SCV000212633Agnes Ginges Centre for Molecular Cardiology, Centenary Institute
criteria provided, single submitter

(Agnes Ginges Centre for Molecular Cardiology criteria (2015))
Pathogenicgermlineresearch

PubMed (12)
[See all records that cite these PMIDs]

Citation Link,

SCV000256122Laboratory of Genetics and Molecular Cardiology, University of São Paulo - Sarcomeric Human Cardiomyopathy Registry (ShaRe)
criteria provided, single submitter

(LGCM Criteria August 2015)
Likely pathogenicgermlineclinical testing

PubMed (4)
[See all records that cite these PMIDs]

LGCM_Criteria_August_2015,

Citation Link,

SCV004045796Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München
criteria provided, single submitter

(Classification criteria August 2017)
Pathogenic
(Jun 27, 2023)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineyes41not providednot providednot providedclinical testing, research
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy.

Watkins H, Rosenzweig A, Hwang DS, Levi T, McKenna W, Seidman CE, Seidman JG.

N Engl J Med. 1992 Apr 23;326(17):1108-14.

PubMed [citation]
PMID:
1552912

Independent origin of identical beta cardiac myosin heavy-chain mutations in hypertrophic cardiomyopathy.

Watkins H, Thierfelder L, Anan R, Jarcho J, Matsumori A, McKenna W, Seidman JG, Seidman CE.

Am J Hum Genet. 1993 Dec;53(6):1180-5.

PubMed [citation]
PMID:
8250038
PMCID:
PMC1682496
See all PubMed Citations (13)

Details of each submission

From OMIM, SCV000035402.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (2)

Description

See 160760.0002. Watkins et al. (1992) found substitution of cysteine for arginine-453 in 2 unrelated families with familial hypertrophic cardiomyopathy (CMH1; 192600). One of the families also had an alpha/beta cardiac myosin heavy chain hybrid gene which was presumably of no functional significance, inasmuch as the 5-prime promoter region was derived from the alpha subunit.

In a 3-generation Chinese family, Ko et al. (1996) observed the coexistence of sudden death and end-stage heart failure due to the arg453-to-cys mutation. The average age of death in affected members of the family was 34 years.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

From Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, SCV000212633.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedresearch PubMed (12)

Description

This MYH7 Arg453Cys mutation is well described in the literature. The mutation has been identified in multiple unrelated individuals and families with HCM (see references). This mutation is not a founder mutation but rather, occurs in a well known hotspot region of the MYH7 gene and has an independent origin is each family (Watkins H, et al., 1993). Additionally, a different mutation affecting the same protein position (Arg453Ser) has been identified to also cause HCM (Frazier A, et al., 2008). Interestingly, this MYH7 Arg453Cys mutation has been identified as the cause of disease in the first HCM family described by Teare in 1958 (Watkins H, et al., 1992). This mutation is inherited as an autosomal trait with high penetrance, has been shown to cosegregate with disease, and is associated with unfavourable prognoses in multiple families (Solomon SD, et al., 1990; Watkins H, et al., 1992 & 1993; Ko YL, et al., 1996; Greber-Platzer S, et al., 2001). We have identified this mutation in one HCM family from our cohort. Based on the available literature, segregation analysis, and absence in the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/), we classify this variant as "pathogenic".

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot providednot providednot provided1not provided

From Laboratory of Genetics and Molecular Cardiology, University of São Paulo - Sarcomeric Human Cardiomyopathy Registry (ShaRe), SCV000256122.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided3not providednot providedclinical testing PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided3not providednot providednot provided

From Institute of Human Genetics Munich, Klinikum Rechts Der Isar, TU München, SCV004045796.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided1not providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineyesnot providednot providednot provided1not providednot providednot provided

Last Updated: Nov 10, 2024